Impact of Aligner Replacement Protocols on Predictability of Planned Dental Movements: Evaluation of Double Aligner
Launched by NEODENT · Mar 12, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This prospective clinical trial aims to determine whether replacing an aligner after 7 days with a new aligner of a different material affects the predictability of planned dental movements. A total of 114 adult patients undergoing orthodontic treatment with aligners-requiring bilateral tooth movements (extrusion, intrusion, rotation, tipping, or mesiodistal translation)-will be recruited and randomized into three groups with distinct aligner exchange protocols.
Group 1: 10 days of exclusive FLX aligner use. Group 2: 7 days of FLX aligner use followed by 3 days of FLX35 use. Group 3: 7 day...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years or older, with full permanent dentition.
- • Interested in orthodontic treatment with aligners.
- • Planned movements include extrusion, intrusion, rotation, tipping, or mesiodistal translation.
- • Signed informed consent.
- Exclusion Criteria:
- • Contraindications to aligner use, including allergies to polyurethane or PETG.
- • Poor oral hygiene or active periodontal disease.
- • Malocclusions involving multiple missing teeth or short clinical crowns.
About Neodent
Neodent, a leading global provider of dental implants and solutions, specializes in innovative technologies and products that enhance dental restoration and rehabilitation. With a commitment to advancing oral healthcare, Neodent invests in research and development, ensuring that its clinical trials adhere to the highest standards of safety and efficacy. The company collaborates with dental professionals and institutions worldwide to explore new methodologies and improve patient outcomes, positioning itself at the forefront of dental innovation and excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Curitba, Paraná, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported